Skip navigation | ||
|
||
Other drug names: | A-Am An-Az B C-Ch Ci-Cz D-Dh Di-Dz E F G H I-J K-L M-Mh Mi-Mz N-Nh Ni-Nz O P-Pl Pm-Pz Q-R S-Sn So-Sz T-To Tp-Tz U-V W-Z 0-9 |
Contents of this page: | |
In the U.S.—
|
Pemirolast ( pe-MEER-oh-last) is used to treat the itching in your eyes that happens with allergies.
Pemirolast works by preventing certain types of inflammatory cells from releasing irritating substances that cause allergic symptoms.
This medicine is available only with your doctor's prescription, in the following dosage forms:
In deciding to use a medicine, the risks of using the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For pemirolast, the following should be considered:
Allergies—Tell your doctor if you have ever had any unusual or allergic reaction to pemirolast. Also tell your doctor and pharmacist if you are allergic to any other substances, such as [foods, preservatives, or dyes].
Pregnancy—Pemirolast has not been shown to cause birth defects or other problems in humans. However, in rats given 20,000 to 30,000 times the human dose of pemirolast, there was an increase in the number of fetal bone and heart deformities as well as an increased number of fetal implantation losses.
Breast-feeding—It is not known whether pemirolast passes into human breast milk. Although most medicines pass into breast milk in small amounts, many of them may be used safely while breast feeding. Mothers who are taking this medicine and who wish to breast-feed should discuss this with their doctor.
Children—This medicine has been tested in children 3 years of age and older and, in effective doses, has not been shown to cause different side effects or problems than it does in adults.
Older adults—There is no specific information available comparing the use of pemirolast in the elderly with use in other age groups.
Pemirolast is used to help treat the itching that often occurs with allergic conjunctivitis.
Dosing—
Use this medicine only as directed. Do not use more of it and do not use it more often than your doctor ordered.
Follow your doctor's orders or the directions on the label. The following information includes only the average dose of ophthalmic pemirolast. If your dose is different, do not change it unless your doctor tells you to do so.
Missed dose—
If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Storage—
To store this medicine:
You should avoid wearing contact lenses when your eyes are red and irritated from your allergies.
For patients who continue to wear contact lenses and whose eyes are not red, be certain to wait at least 10 minutes after applying pemirolast to your eyes before replacing any contact lenses normally worn.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Other side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. However, check with your doctor if any of the following side effects continue or are bothersome.
Other side effects not listed above may also occur in some patients. If you notice any other effects, check with your doctor.
Copyright© 2003 Thomson MICROMEDEX. All rights reserved. USP DI® and Advice for the Patient® are registered trademarks of USP used under license to Micromedex, a business of Thomson Healthcare Inc. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Home | Health Topics | Drug Information | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Selection Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 22 October 2004 |